1972. Safety and Immunogenicity of 15-Valent Pneumococcal Conjugate Vaccine (PCV-15) Compared with PCV-13 in Healthy Older Adults Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23)

BACKGROUND: Safety and immunogenicity of a new formulation of PCV-15 (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19F, 19A, 22F*, 23F, 33F*) was evaluated in adults ≥65 years of age previously vaccinated with PPV23. METHODS: Study subjects who received PPV23 at least 1 year prior to study entry received a...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Open Forum Infect Dis
المؤلفون الرئيسيون: Buchwald, Ulrike, Peterson, James, Stacey, Helen, Julien, Katie, Sterling, Tina, Bruch, Melanie, Tamms, Gretchen, Li, Jianing, Pedley, Alison, Nolan, Katrina, Benner, Patrice, Abeygunawardana, Chitrananda, Winters, Michael, Kosinski, Michael, Stek, Jon, Musey, Luwy
التنسيق: Artigo
اللغة:Inglês
منشور في: Oxford University Press 2018
الموضوعات:
Abstracts
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6253634/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.1628
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة